Breaking News Instant updates and real-time market news.

ONDK

On Deck Capital

$8.81

0.195 (2.26%)

06:20
08/14/18
08/14
06:20
08/14/18
06:20

On Deck Capital downgraded to Sell from Neutral at BTIG

BTIG analyst Mark Palmer downgraded On Deck Capital to Sell from Neutral with a price target of $7 despite the surge in the stock price last week after its Q2 earnings beat and raised FY18 guidance. The analyst points to the company's "overextended" valuation at 17.7-times and 14.8-times respective estimated earnings for FY19 and FY20 and questions whether it will be able to generate "meaningful" EPS growth without assumptions of higher yields or falling charge-offs. Palmer further states that the current valuation would require him to make "essentially blind assumptions" about the growth the company's On Deck as a Service platform, contribution of which the management is yet to break out in its reported results.

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 06

    Nov

ONDK On Deck Capital
$8.81

0.195 (2.26%)

07/19/18
07/19/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. NEEDHAM CUTS TESLA TO UNDERPERFORM: Needham analyst Rajvindra Gill downgraded Tesla (TSLA) to Underperform from Hold, stating the stock remains overvalued in spite of its 16% decline from the the June 2017 peak. The analyst cited expectations of slower Model S/X sales amid increased competition and possible cannibalization from the Model 3, the expiration of credits, slower gross margins improvement with "persistently high" production costs, lower energy segment revenue after recent restructuring, and Tesla's "unsustainable capital structure." Tesla is down 1.9% in midday trading. CREDIT SUISSE UPGRADES SQUARE: Credit Suisse analyst Paul Condra upgraded Square (SQ) to Outperform from Neutral, saying he believes its growing product eco-system is increasing its ability to penetrate larger merchants. He also said positive data points on Cash-App adoption validate Square's two-sided platform strategy to grow both merchant and consumer use-cases. The analyst also raised his price target on the shares to $81 from $44. MORGAN STANLEY UPS SQUARE TARGET: Morgan Stanley analyst James Faucette sees good potential for upward estimate revisions for Square in the near-term and raised his price target on the stock to $75 from $43. However, Faucette kept an Equal Weight rating on Square, calling its valuation "demanding" and citing his continued view that new services are misvalued. Square is higher by 3.5% at midday. MORGAN STANLEY DOWNGRADES LENDINGCLUB, ON DECK: Morgan Stanley's Faucette downgraded LendingClub (LC) to Equal Weight from Overweight as he thinks the previously disclosed FTC investigation into the company's lending practices will be a drag on new investor interest and involvement in the stock until it is resolved. Faucette lowered his price target on LendingClub shares to $5 from $6. Faucette downgraded On Deck Capital (ONDK) to Underweight from Equal Weight, stating that he sees the company needing a long time to meaningfully scale the "OnDeck-as-a-Service," which he believes will limit the stock's potential for valuation expansion above small-to-mid cap banks. Also, Faucette sees limited upside potential to origination growth estimates given the company's preference for delivering profitability versus growth, he tells investors. PIPER POSITIVE ON CISCO AND ARISTA, CALLS AMAZON FEARS OVERBLOWN: Amazon (AMZN) is not entering the network switching market as speculated on July 13, Piper Jaffray analyst James Fish told investors in a research note. The confirmation by Amazon removes the potential shadow of Amazon on the space. The analyst continued to recommend Cisco (CSCO) and Arista (ANET) as his top networking picks.
07/19/18
MSCO
07/19/18
NO CHANGE
MSCO
Morgan Stanley upgrades Payments and Processing industry to Attractive
Morgan Stanley analyst James Faucette upgraded his view of the Payments and Processing industry to Attractive, citing the firm's U.S. Strategy Team's call for rotation out of Technology and his view that Payments will be seen as an attractive option for investors looking to become more defensive. Investors underappreciate the resilience of consumer spending and Faucette sees the potential for his Payments coverage market-cap weighted earnings growth to accelerate organically to 15% over 2018-2020 from 11% growth over the last three years, he tells investors. In the group, the firm has Overweight ratings on Visa (V), MasterCard (MA), PayPal (PYPL), GreenSky (GSKY), Worldpay (WP) and FleetCor (FLT). Morgan Stanley has Underweight ratings on Western Union (WU) and On Deck Capital (ONDK), having downgraded On Deck this morning.
07/19/18
07/19/18
DOWNGRADE
Target $6

Underweight
Morgan Stanley sees On Deck needing time to ramp ODaaS, cuts to Underweight
As previously reported, Morgan Stanley analyst James Faucette downgraded On Deck Capital to Underweight from Equal Weight, stating that he sees the company needing a long time to meaningfully scale the "OnDeck-as-a-Service," which he believes will limit the stock's potential for valuation expansion above small-to-mid cap banks. Also, Faucette sees limited upside potential to origination growth estimates given the company's preference for delivering profitability versus growth, he tells investors. He maintains a $6 price target on On Deck shares.
07/19/18
MSCO
07/19/18
DOWNGRADE
MSCO
Underweight
On Deck Capital downgraded to Underweight from Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

DCO

Ducommun

$38.00

0.2 (0.53%)

07:13
12/12/18
12/12
07:13
12/12/18
07:13
Initiation
Ducommun initiated  »

Ducommun initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSDT

Helius Medical

$9.94

-0.33 (-3.21%)

07:12
12/12/18
12/12
07:12
12/12/18
07:12
Hot Stocks
Helius Medical announces PoNS application for CE Mark »

Helius Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$15.50

0.16 (1.04%)

07:12
12/12/18
12/12
07:12
12/12/18
07:12
Recommendations
Intra-Cellular analyst commentary  »

Intra-Cellular's NDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

MNGPY

Man Group

$0.00

(0.00%)

07:11
12/12/18
12/12
07:11
12/12/18
07:11
Downgrade
Man Group rating change  »

Man Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCY

Oncolytics

$2.03

0.01 (0.50%)

, BMY

Bristol-Myers

$52.44

-0.15 (-0.29%)

07:10
12/12/18
12/12
07:10
12/12/18
07:10
Hot Stocks
Oncolytics treats first patient in pelareorep, carfilzomib with Opdivo trial »

Oncolytics (ONCY)…

ONCY

Oncolytics

$2.03

0.01 (0.50%)

BMY

Bristol-Myers

$52.44

-0.15 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 29

    Dec

  • 24

    Jan

  • 20

    May

UNIT

Uniti Group

$19.59

0.52 (2.73%)

07:10
12/12/18
12/12
07:10
12/12/18
07:10
Downgrade
Uniti Group rating change  »

Uniti Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$207.29

-0.545 (-0.26%)

07:09
12/12/18
12/12
07:09
12/12/18
07:09
Hot Stocks
Lennox sees $347M in insurance proceeds for 2018, 2019 »

Overall for 2018 and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SRNE

Sorrento Therapeutics

$2.66

-0.27 (-9.22%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Recommendations
Sorrento Therapeutics analyst commentary  »

Sorrento Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$7.28

-0.37 (-4.84%)

, GE

General Electric

$6.77

-0.15 (-2.17%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Hot Stocks
McDermott, Baker Hughes, selected for Equus Gas Project in Australia »

McDermott (MDR), with…

MDR

McDermott

$7.28

-0.37 (-4.84%)

GE

General Electric

$6.77

-0.15 (-2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$135.79

2.32 (1.74%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Hot Stocks
Molina Healthcare awarded CHIP contract in Mississippi »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

Aveo Pharmaceuticals

$2.03

0.01 (0.50%)

, AZN

AstraZeneca

$38.63

0.22 (0.57%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Hot Stocks
Aveo Oncology announces immuno-oncology clinical collaboration with AstraZeneca »

AVEO Oncology (AVEO)…

AVEO

Aveo Pharmaceuticals

$2.03

0.01 (0.50%)

AZN

AstraZeneca

$38.63

0.22 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRMN

Garmin

$65.37

0.41 (0.63%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Hot Stocks
Garmin Health, ActiGraph collaborate on wearable solutions for clinical trials »

Garmin International, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BIOS

BioScrip

$3.84

0.1 (2.67%)

07:08
12/12/18
12/12
07:08
12/12/18
07:08
Initiation
BioScrip initiated  »

BioScrip initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$207.29

-0.545 (-0.26%)

07:07
12/12/18
12/12
07:07
12/12/18
07:07
Hot Stocks
Lennox sees FY18 CapEx approximately $125M »

Including $25M in 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

APHA

Aphria

$6.14

0.55 (9.84%)

07:06
12/12/18
12/12
07:06
12/12/18
07:06
Hot Stocks
Aphria signs letter of intent to supply medical cannabis in Paraguay »

Aphria has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKIS

Peak Resorts

$4.98

-0.01 (-0.20%)

07:06
12/12/18
12/12
07:06
12/12/18
07:06
Earnings
Peak Resorts reports Q2 EPS (81c) vs. (66c) last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AMRH

AMERI Holdings

$0.25

-0.0061 (-2.38%)

07:06
12/12/18
12/12
07:06
12/12/18
07:06
Hot Stocks
AMERI Holdings names founder Dev Nidhi as Executive Chairman »

AMERI Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$207.29

-0.545 (-0.26%)

07:05
12/12/18
12/12
07:05
12/12/18
07:05
Hot Stocks
Lennox sees FY19 CapEx approximately $215M »

Including $115M in 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

07:05
12/12/18
12/12
07:05
12/12/18
07:05
General news
European stock markets are broadly higher »

European stock markets…

CRMD

CorMedix

$1.58

-0.08 (-4.82%)

07:04
12/12/18
12/12
07:04
12/12/18
07:04
Recommendations
CorMedix analyst commentary  »

CorMedix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$17.93

-0.02 (-0.11%)

07:04
12/12/18
12/12
07:04
12/12/18
07:04
Hot Stocks
Breaking Hot Stocks news story on JetBlue »

JetBlue sees Q4 RASM up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$207.29

-0.545 (-0.26%)

07:03
12/12/18
12/12
07:03
12/12/18
07:03
Earnings
Lennox sees FY19 adjusted EPS $12.00-$12.60, consensus $11.84 »

Sees FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

07:03
12/12/18
12/12
07:03
12/12/18
07:03
General news
MBA Mortgage Applications Composite Index data reported »

Week of 12/7 MBA Mortgage…

JBLU

JetBlue

$17.93

-0.02 (-0.11%)

07:03
12/12/18
12/12
07:03
12/12/18
07:03
Hot Stocks
JetBlue reports preliminary November traffic up 9.7% »

JetBlue Airways…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDE

Coeur Mining

$3.98

-0.145 (-3.52%)

07:03
12/12/18
12/12
07:03
12/12/18
07:03
Hot Stocks
Coeur Mining provides 2018 exploration update »

Coeur provided an update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.